Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
about
Primary Antibiotic Resistance of Helicobacter pylori in China.Treatment of Helicobacter pylori infection 2016.Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Hybrid Therapy Regimen for Helicobacter Pylori EradicationTailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-AnalysisRandomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection.H. pylori Management in ASEAN: the Bangkok Consensus Report.Recurrence of Helicobacter pylori infection and the affecting factors: A follow-up study.High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland.Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates.Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradication.
P2860
Q30235219-0996659E-F34F-4F6F-8D9F-F80FCC947E2EQ30248450-EB5B46D6-7AE6-42B0-A0CF-9C3B1BE2C61EQ33562959-F0BD1CE1-7517-4B21-8152-067689BCBE8BQ33639114-F1E25996-F525-4A4B-80D3-08C64FD50FE3Q36797844-A1D44E46-BB29-4567-81A8-257A87E6269CQ37206124-A58536E6-38DE-4FCA-9856-FC4F5D27BE7FQ38846038-1DAFFEED-1E05-4C80-8293-A2D85597904AQ39316784-BC65F4E7-727C-4494-998E-847943192FFFQ40100019-71A464FD-581C-4A71-A363-107B9BA8A5FAQ40394250-6A1436B9-F8C1-4A09-A3FA-0D9B480A043EQ40438856-FD90CBFF-47A0-4587-B609-098BB662E6ABQ40702356-05087DD4-00B7-4C43-9C53-4A90F3C49E75Q40818792-0CF67A6D-EC97-4431-9B39-F42E58D181EEQ42362197-8DC1D28A-BD58-475E-BD50-10386C8151E0Q47222389-8FF01F25-5A45-4335-83F5-3EE3ADD659A9
P2860
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tailored versus Triple plus Bi ...... Treatment: A Randomized Trial.
@en
type
label
Tailored versus Triple plus Bi ...... Treatment: A Randomized Trial.
@en
prefLabel
Tailored versus Triple plus Bi ...... Treatment: A Randomized Trial.
@en
P2093
P2860
P356
P1433
P1476
Tailored versus Triple plus Bi ...... Treatment: A Randomized Trial.
@en
P2093
Jiaming Qian
Jianzhong Zhang
Sanren Lin
Yanqing Li
Zhiqiang Song
P2860
P356
10.1111/HEL.12242
P577
2015-06-23T00:00:00Z